08 Mar 2024
07:00 CET |
MITHRA |
Mithra reports full year 2023 financial results
|
20103015 Pharmaceuticals |
- |
05 Mar 2024
07:01 CET |
MITHRA |
Mithra announces changes to its executive management
|
20103015 Pharmaceuticals |
- |
05 Mar 2024
07:00 CET |
MITHRA |
Mithra initiates monetization process, receives bridge loan from existing lenders
|
20103015 Pharmaceuticals |
- |
29 Feb 2024
11:42 CET |
MITHRA |
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
|
20103015 Pharmaceuticals |
- |
15 Feb 2024
18:23 CET |
MITHRA |
Mithra sells shares in Mayne Pharma
|
20103015 Pharmaceuticals |
- |
06 Feb 2024
07:00 CET |
MITHRA |
Mithra updates on cash position
|
20103015 Pharmaceuticals |
- |
21 Dec 2023
17:45 CET |
MITHRA |
Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel
|
20103015 Pharmaceuticals |
- |
20 Dec 2023
17:45 CET |
MITHRA |
Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients
|
20103015 Pharmaceuticals |
- |
18 Dec 2023
07:00 CET |
MITHRA |
Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial
|
20103015 Pharmaceuticals |
- |
04 Dec 2023
07:00 CET |
MITHRA |
Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China
|
20103015 Pharmaceuticals |
- |
30 Nov 2023
07:00 CET |
MITHRA |
Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States
|
20103015 Pharmaceuticals |
- |
28 Nov 2023
17:45 CET |
MITHRA |
Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam
|
20103015 Pharmaceuticals |
- |
07 Nov 2023
07:00 CET |
MITHRA |
Mithra’s NEXTSTELLIS® granted additional patent in the United States
|
20103015 Pharmaceuticals |
- |
06 Nov 2023
18:52 CET |
MITHRA |
Mithra releases invitation to its extraordinary securities holders’ meeting
|
20103015 Pharmaceuticals |
- |
26 Oct 2023
07:00 CEST |
MITHRA |
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
|
20103015 Pharmaceuticals |
- |
23 Oct 2023
07:00 CEST |
MITHRA |
Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement
|
20103015 Pharmaceuticals |
- |
17 Oct 2023
07:00 CEST |
MITHRA |
Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting
|
20103015 Pharmaceuticals |
- |
11 Oct 2023
07:15 CEST |
MITHRA |
Shareholder Letter
|
20103015 Pharmaceuticals |
- |
11 Oct 2023
07:00 CEST |
MITHRA |
Mithra announces update to the agenda of its upcoming special general shareholders’ meeting
|
20103015 Pharmaceuticals |
- |
10 Oct 2023
18:00 CEST |
MITHRA |
Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress
|
20103015 Pharmaceuticals |
- |
05 Oct 2023
07:00 CEST |
MITHRA |
Mithra Provides an Update in the Context of Recent Market Developments
|
20103015 Pharmaceuticals |
- |
28 Sep 2023
09:45 CEST |
MITHRA |
Mithra prices private placement to raise EUR 20 million in equity
|
20103015 Pharmaceuticals |
Corporate life |
28 Sep 2023
09:42 CEST |
MITHRA |
Mithra Financial Results for First-Half 2023
|
20103015 Pharmaceuticals |
Commercial results |
27 Sep 2023
07:00 CEST |
MITHRA |
Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023
|
20103015 Pharmaceuticals |
- |
26 Sep 2023
07:00 CEST |
MITHRA |
Mithra Financial Results for First-Half 2023
|
20103015 Pharmaceuticals |
- |
22 Sep 2023
13:30 CEST |
MITHRA |
Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET
|
20103015 Pharmaceuticals |
- |
21 Sep 2023
17:55 CEST |
MITHRA |
Information on the total number of voting rights (denominator)
|
20103015 Pharmaceuticals |
- |
21 Sep 2023
17:55 CEST |
MITHRA |
Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST
|
20103015 Pharmaceuticals |
- |
12 Sep 2023
17:45 CEST |
MITHRA |
Publication of a Transparency Notification Received from Armistice Capital, LLC
|
20103015 Pharmaceuticals |
- |
12 Sep 2023
17:45 CEST |
MITHRA |
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
|
20103015 Pharmaceuticals |
- |
11 Sep 2023
07:30 CEST |
MITHRA |
Letter to Shareholders and Corporate Update
|
20103015 Pharmaceuticals |
- |
28 Aug 2023
17:45 CEST |
MITHRA |
Mithra completes EUR 20 million private placement in equity Update of total number of voting rights (denominator)
|
20103015 Pharmaceuticals |
- |
24 Aug 2023
07:33 CEST |
MITHRA |
Mithra prices private placement to raise EUR 20 million in equity
|
20103015 Pharmaceuticals |
- |
16 Jun 2023
08:55 CEST |
MITHRA |
Mithra Announces Sale of Shares in Mayne Pharma
|
20103015 Pharmaceuticals |
Other financial transaction |
25 Apr 2023
16:06 CEST |
MITHRA |
Mithra Releases Invitation to its General Shareholders’ Meeting
|
20103015 Pharmaceuticals |
General meeting / Board Meeting |
18 Apr 2023
11:16 CEST |
MITHRA |
Mithra releases 2022 Annual Report
|
20103015 Pharmaceuticals |
Corporate life |
27 Sep 2022
09:40 CEST |
MITHRA |
Mithra 2022 Half Year Results
|
20103015 Pharmaceuticals |
Commercial results |
17 Aug 2022
16:10 CEST |
MITHRA |
Mithra obtains funding for up to EUR 100 Million from existing investors and repurchases EUR 34.1 million of its convertible bonds due 2025 at a discount to par
|
20103015 Pharmaceuticals |
Other financial transaction |
17 Aug 2022
15:39 CEST |
MITHRA |
Mithra Completes a EUR 23.5 Million Private Placement
|
20103015 Pharmaceuticals |
Change in Capital |
17 Aug 2022
15:31 CEST |
MITHRA |
Mithra 2021 Full Year Results
|
20103015 Pharmaceuticals |
Commercial results |
17 Aug 2022
15:22 CEST |
MITHRA |
Mithra résultats semestriels 2021
|
20103015 Pharmaceuticals |
Commercial results |
17 Aug 2022
15:18 CEST |
MITHRA |
Mithra 2021 Half Year Results
|
20103015 Pharmaceuticals |
Commercial results |
09 Mar 2021
07:54 CET |
MITHRA |
Mithra annonce ses résultats annuels 2020
|
20103015 Pharmaceuticals |
Commercial results |
09 Mar 2021
07:52 CET |
MITHRA |
Mithra Reports Full Year 2020 Financial Results
|
20103015 Pharmaceuticals |
Commercial results |
21 Jan 2021
15:30 CET |
MITHRA |
Mithra announces placement of EUR 125 million convertible bonds due 2025
|
20103015 Pharmaceuticals |
Other financial transaction |
21 Jan 2021
15:26 CET |
MITHRA |
First Half 2020 financial report
|
20103015 Pharmaceuticals |
Corporate life |
18 Jun 2020
20:45 CEST |
MITHRA |
Mithra Successfully Raises EUR 65.0 Million By Means of a Private Placement via an Accelerated Bookbuild Offering
|
20103015 Pharmaceuticals |
Change in Capital |
18 Jun 2020
14:39 CEST |
MITHRA |
Mithra Launches Capital Increase By Means of a Private Placement via an Accelerated Bookbuild Offering and Provides an Update on its Financing Strategy
|
20103015 Pharmaceuticals |
Change in Capital |
09 Mar 2020
07:30 CET |
MITHRA |
Mithra Reports Full Year 2019 Financial Results
|
Pharmaceuticals |
Corporate life |
09 Mar 2020
07:30 CET |
MITHRA |
Mithra annonce ses résultats annuels 2019
|
Pharmaceuticals |
Corporate life |